A spokesperson for FFF Enterprises did not immediately respond to the Washington Examiner's request for comment. It is unclear what percentage of the initial investment the state could regain if the return is accepted. The U.S. Food and Drug Administration reversed its emergency use authorization for hydroxychloroquine and chloroquine in June, citing studies the drug commonly used to treat malaria lacked evidence to show it is safe and effective to treat the COVID-19 virus. Gov. Kevin Stitt faced criticism in 2020 for purchasing the stockpile of hydroxychloroquine but defended it at the time as an exercise of caution, similar to securing personal protective equipment and other supplies to stave off the pandemic, according to the